2017 Harrington Prize Co-Recipient
Joel F. Habener, M.D. received his B.S. degree Cum Laude in 1960 from the University of Redlands, Redlands, California and in 1965 his M.D degree from the University of California School of Medicine, Los Angeles, California. Dr. Habener is Professor of Medicine at the Harvard Medical School, Associate Physician at the Massachusetts General Hospital, and a former Investigator with the Howard Hughes Medical Institute. He is the Director of the Laboratory of Molecular Endocrinology in the Department of Medicine at the Massachusetts General Hospital. His research interests are in the fields of obesity, diabetes, and metabolism with a focus on the interactions of growth factors and morphogens on the expression of transcription factors during development and in the regulation of hormone production by endocrine organs of the body. He has authored over 450 research articles, books and reviews on these subjects. He is a discoverer of the insulinotropic hormone glucagon-like peptide-1, cyclic AMP response element binding protein, the islet duodenal homeodomain protein, and the existence of multipotent stem cells in the pancreas. Dr. Habener holds several patents on these discoveries. Dr. Habener’s discoveries contributed to the development of glucagon-like peptide-1, currently on the market as a treatment for diabetes. Dr. Habener is a member of several editorial boards of scientific journals and has served on many advisory committees of pharmaceutical companies and the National Institutes of Health. He is the recipient of several awards, including the Robert H. Williams Distinguished Leadership Award by the Endocrine Society in 1999.